{"id":"https://openalex.org/W3163671997","doi":"https://doi.org/10.1176/appi.ps.202000338","title":"Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011\u20132016","display_name":"Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011\u20132016","publication_year":2021,"publication_date":"2021-05-21","ids":{"openalex":"https://openalex.org/W3163671997","doi":"https://doi.org/10.1176/appi.ps.202000338","mag":"3163671997","pmid":"https://pubmed.ncbi.nlm.nih.gov/34015964"},"language":"en","primary_location":{"id":"doi:10.1176/appi.ps.202000338","doi":"https://doi.org/10.1176/appi.ps.202000338","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ps.202000338","pdf_url":null,"source":{"id":"https://openalex.org/S171176648","display_name":"Psychiatric Services","issn_l":"0022-1597","issn":["0022-1597","1075-2730","1557-9700"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatric Services","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021628609","display_name":"Brianna Costales","orcid":"https://orcid.org/0000-0002-5334-2712","observed_orcids":["https://orcid.org/0000-0002-5334-2712"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brianna Costales","raw_affiliation_strings":["Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Center for Drug Evaluation and Safety, University of Florida, Gainesville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Center for Drug Evaluation and Safety, University of Florida, Gainesville","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011274790","display_name":"Amie J. Goodin","orcid":"https://orcid.org/0000-0002-0020-8720","observed_orcids":["https://orcid.org/0000-0002-0020-8720"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amie J. Goodin","raw_affiliation_strings":["Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Center for Drug Evaluation and Safety, University of Florida, Gainesville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Center for Drug Evaluation and Safety, University of Florida, Gainesville","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I33213144"],"apc_list":null,"apc_paid":null,"fwci":2.3788,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.87821994,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"72","issue":"11","first_page":"1246","last_page":"1253"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.8389000296592712,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.8389000296592712,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.11020000278949738,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.906000018119812},{"id":"https://openalex.org/keywords/psychiatric-prescribing","display_name":"psychiatric prescribing","score":0.7649999856948853},{"id":"https://openalex.org/keywords/central-nervous-system-depressants","display_name":"central nervous system depressants","score":0.9700000286102295},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6039999723434448},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9049999713897705},{"id":"https://openalex.org/keywords/opioids","display_name":"opioids","score":0.9020000100135803},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5889999866485596},{"id":"https://openalex.org/keywords/fda-warning","display_name":"FDA warning","score":0.45899999141693115},{"id":"https://openalex.org/keywords/depressive-disorders","display_name":"depressive disorders","score":0.5419999957084656},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.9620000123977661},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/outpatient-prescriptions","display_name":"outpatient prescriptions","score":0.6069999933242798},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.5640000104904175},{"id":"https://openalex.org/keywords/provider-specialty","display_name":"provider specialty","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.9433190822601318},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.845157265663147},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6899877786636353},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.5543882250785828},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5071432590484619},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4119647145271301},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19584178924560547},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.15136033296585083},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.10769414901733398},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010045","descriptor_name":"Outpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D056687","descriptor_name":"Off-Label Use","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1176/appi.ps.202000338","doi":"https://doi.org/10.1176/appi.ps.202000338","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ps.202000338","pdf_url":null,"source":{"id":"https://openalex.org/S171176648","display_name":"Psychiatric Services","issn_l":"0022-1597","issn":["0022-1597","1075-2730","1557-9700"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatric Services","raw_type":"journal-article"},{"id":"pmid:34015964","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34015964","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatric services (Washington, D.C.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1678598210","https://openalex.org/W2001464002","https://openalex.org/W2019364045","https://openalex.org/W2042746585","https://openalex.org/W2129408669","https://openalex.org/W2135796490","https://openalex.org/W2137996324","https://openalex.org/W2159492208","https://openalex.org/W2187057644","https://openalex.org/W2233618464","https://openalex.org/W2472722576","https://openalex.org/W2761666829","https://openalex.org/W2775546535","https://openalex.org/W2779818041","https://openalex.org/W2782300316","https://openalex.org/W2790080337","https://openalex.org/W2793386076","https://openalex.org/W2894221331","https://openalex.org/W2902934935","https://openalex.org/W2903083624","https://openalex.org/W2924513576","https://openalex.org/W2944225064","https://openalex.org/W2970374048","https://openalex.org/W2996776613","https://openalex.org/W3011417498","https://openalex.org/W3044959010","https://openalex.org/W3086919273","https://openalex.org/W4298279255"],"related_works":["https://openalex.org/W3028062019","https://openalex.org/W2886489185","https://openalex.org/W2145682210","https://openalex.org/W7033421335","https://openalex.org/W7052030988","https://openalex.org/W4387187993","https://openalex.org/W4386466943","https://openalex.org/W2955342168","https://openalex.org/W2036504872","https://openalex.org/W2946401246"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Gabapentin":[1],"is":[2],"widely":[3],"prescribed":[4,36],"off":[5],"label":[6],"in":[7,37],"medical":[8],"practice,":[9],"including":[10],"psychiatry.":[11],"The":[12],"U.S.":[13],"Food":[14],"and":[15,50,69,92,97,132,157,169,202],"Drug":[16],"Administration":[17],"(FDA)":[18],"warned":[19],"of":[20,76,100,107,140,188,199],"risks":[21],"associated":[22],"with":[23,26,164],"gabapentin":[24,45,103,121,142,161,190,204],"combined":[25],"central":[27],"nervous":[28],"system":[29],"depressant":[30],"(CNS-D)":[31],"drugs,":[32],"which":[33],"are":[34],"commonly":[35],"psychiatric":[38,48,206],"treatment.":[39],"This":[40],"study":[41],"examined":[42,60],"off-label":[43,120,141,203],"outpatient":[44,189],"use":[46,191,198],"for":[47,193,205,211],"indications":[49],"concomitant":[51,148,197],"CNS-D":[52,58,80,149,200],"medication":[53],"use.":[54],"METHODS:":[55],"diagnosis":[56],"codes.":[57],"drugs":[59,201],"were":[61,87,163],"opioids,":[62],"benzodiazepines,":[63],"sedatives-hypnotics,":[64],"antidepressants,":[65],"antipsychotics,":[66],"first-generation":[67],"antihistamines,":[68],"skeletal":[70],"muscle":[71],"relaxants.":[72],"Concomitance":[73],"was":[74,192],"prescription":[75],"one":[77,145],"or":[78,146,178],"more":[79,147],"medications":[81],"at":[82],"the":[83,209],"same":[84],"visit.":[85],"Visits":[86],"stratified":[88],"by":[89],"provider":[90,171],"type":[91],"specialty.":[93],"RESULTS:":[94],"Between":[95],"2011":[96],"2016,":[98],"2.8%":[99],"visits":[101,143,162],"listed":[102,115,124,144],"prescriptions":[104],"(weighted":[105],"estimate":[106],"129.6":[108],"million":[109],"visits).":[110],"A":[111],"small":[112],"proportion":[113],"(<1%)":[114],"an":[116,129],"FDA-approved":[117],"indication.":[118],"Among":[119],"visits,":[122],"5.3%":[123],"a":[125],"depressive":[126],"disorder,":[127,131],"3.5%":[128],"anxiety":[130],"1.8%":[133],"bipolar":[134],"disorder.":[135],"Over":[136],"6":[137],"years,":[138],"58.4%":[139],"medications,":[150],"most":[151],"frequently":[152],"antidepressants":[153],"(24.3%),":[154],"opioids":[155],"(22.9%),":[156],"benzodiazepines":[158],"(17.3%).":[159],"Most":[160],"primary":[165,175],"care":[166],"providers":[167],"(34.9%)":[168],"other":[170],"specialties":[172],"(i.e.,":[173],"not":[174],"care,":[176],"neurology,":[177],"psychiatry)":[179],"(48.1%).":[180],"CONCLUSION:":[181],"In":[182],"this":[183],"nationally":[184],"representative":[185],"sample,":[186],"<1%":[187],"approved":[194],"indications.":[195],"High":[196],"diagnoses":[207],"underlines":[208],"need":[210],"improved":[212],"communication":[213],"about":[214],"safety.":[215]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-05-24T00:00:00"}